anonymous
Guest
anonymous
Guest
Here's another good show by Alexion Pharma...! June-quarter financial results surpassed the consensus estimates of Wall Street analysts, powered by flagship SOLIRIS. No doubt, it's a much-needed boost for Alexion. Taking a cue from the impressive results, CEO Ludwig Hantson upgraded the outlook for the full year......